A hybrid Monte Carlo transport scheme combining event-by-event and condensed-history simulation with a full account of energy-loss straggling was used to study the dosimetric characteristics of the Auger-emitting radionuclides 67Ga, 99mTc, 111In, 123I, 125I and 201Tl at the single-cell level. The influence of the intracellular localization of the Auger radionuclide upon cellular S-values, radial dose rate profiles and dose-volume-histograms (DVHs) was investigated. For the case where the radiopharmaceutical was either internalized into the cytoplasm or remained bound onto the cell surface (non-internalized), the dose to the cell nucleus was found to differ significantly from the MIRD values and other published data. In this case, the assumption of a homogeneous distribution throughout the cell is shown to significantly overestimate the nuclear dose. A dosimetric case study relevant to the radioimmunotherapy of single lymphoma B-cells with 125I and 123I is presented.

This enquiry showed that both (123)I and (125)I have greater potential than (131)I for the treatment of leukemic spread in patients with lymphoma.

Monte Carlo transport calculations of dose point kernels (DPKs) and depth dose profiles (DDPs) in both the vapor and liquid phases of water are presented for electrons with initial energy between 10 keV and 1 MeV. The results are obtained by the MC4 code using three different implementations of the condensed-history technique for inelastic collisions, namely the continuous slowing down approximation, the mixed-simulation with delta-ray transport and the addition of straggling distributions for soft collisions derived from accurate relativistic Born cross sections. In all schemes, elastic collisions are simulated individually based on single-scattering cross sections. Electron transport below 10 keV is performed in an event-by-event mode. Differences on inelastic interactions between the vapor and liquid phase are treated explicitly using our recently developed dielectric response function which is supplemented by relativistic corrections and the transverse contribution. On the whole, the interaction coefficients used agree to better than approximately 5% with NIST/ICRU values. It is shown that condensed phase effects in both DPKs and DDPs practically vanish above 100 keV. The effect of delta-rays, although decreases with energy, is sizeable leading to more diffused distributions, especially for DPKs. The addition of straggling for soft collisions is practically inconsequential above a few hundred keV. An extensive benchmarking with other condensed-history codes is provided.

No abstract

The use of the CSDA methodology may be unsuitable for the sub-micron scale where a more realistic description of electron transport becomes important.

A systematic study of cellular S-factors and absorbed fractions for monoenergetic electrons of initial energy from 1 keV to 1 MeV is presented. The calculations are based on our in-house Monte Carlo codes which have been developed to simulate electron transport up to a few MeV using both event-by-event and condensed-history techniques. An extensive comparison with the MIRD tabulations is presented for spherical volumes of 1-10 microm radius and various source-to-target combinations relevant to the intracellular localization of the emitted electrons. When the primary electron range is comparable to the sphere radius, we find significantly higher values from the MIRD, while with increasing electron energy the escape of delta-rays leads gradually to the opposite effect. The largest differences with the MIRD are found for geometries where the target region is at some distance from the source region (e.g. surface-to-nucleus or cytoplasm-to-nucleus). The sensitivity of the results to different transport approximations is examined. The grouping of inelastic collisions is found adequate as long as delta-rays are explicitly simulated, while the inclusion of straggling for soft collisions has a negligible effect.

No abstract

The present dosimetric analysis shows that biological half-life, subcellular localization, and the proper account of low-energy electrons is critical in assessing the energy deposition inside the targeted cells from the three iodide radioisotopes examined. From a dosimetric point of view and under the present approximations (123)I might be superior to the other two radioiodides in the treatment of microscopic disease in B-cell lymphoma patients.